INOVIOPossible readd on a retracement if we find support at retracement levels. Could break out of wedge structure and long way to find resistance on macro levels
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−5.11 USD
−135.12 M USD
832.01 K USD
25.74 M
About Inovio Pharmaceuticals, Inc.
Sector
CEO
Jacqueline E. Shea
Headquarters
Plymouth Meeting
Website
Founded
1983
FIGI
BBG000BK6YX5
Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.
INO Inovio Pharmaceuticals Options Ahead of EarningsAnalyzing the options chain and the chart patterns of INO Inovio Pharmaceuticals prior to the earnings report this week,
I would consider purchasing the 13usd strike price Calls with
an expiration date of 2024-5-17,
for a premium of approximately $0.25.
If these options prove to be profitable prior
$INO 50% upside potentialNASDAQ:INO had a streak of green weeks recently and currently is trading above a significant resistance at $11.96
- MACD weekly just turned positive
- Vortex index is positive
INO 1D 2 Month Larger TF shows continuation. Time/Space corrective until wave (B). Breakout of falling wedge finished. Retracement and continuation.
Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases a
INO Bullish Deep CrabINO has completed a bottom formation IMO. I believe the bottom has come in a harmonic deep crab formation. I've highlighted the accumulation zone. This is high risk but also has the potential of being a 5 to 100x bagger. Good Luck!
💊 INO SELL THE BREAK 📉INO has broken out of a larger degree correction and continues to make smaller degree flags in the bearish direction.
Stick to your trading rules!
Inovio timeCovid is here to stay!
Data from the WHO will be good. Time to buy and hold. Let the shorts
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of INO is 5.54 USD — it has increased by 0.36% in the past 24 hours. Watch Inovio Pharmaceuticals, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Inovio Pharmaceuticals, Inc. stocks are traded under the ticker INO.
INO stock has risen by 4.53% compared to the previous week, the month change is a −1.95% fall, over the last year Inovio Pharmaceuticals, Inc. has showed a 24.74% increase.
We've gathered analysts' opinions on Inovio Pharmaceuticals, Inc. future price: according to them, INO price has a max estimate of 33.00 USD and a min estimate of 7.00 USD. Watch INO chart and read a more detailed Inovio Pharmaceuticals, Inc. stock forecast: see what analysts think of Inovio Pharmaceuticals, Inc. and suggest that you do with its stocks.
INO stock is 2.39% volatile and has beta coefficient of 1.56. Track Inovio Pharmaceuticals, Inc. stock price on the chart and check out the list of the most volatile stocks — is Inovio Pharmaceuticals, Inc. there?
Today Inovio Pharmaceuticals, Inc. has the market capitalization of 143.84 M, it has decreased by −1.77% over the last week.
Yes, you can track Inovio Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
Inovio Pharmaceuticals, Inc. is going to release the next earnings report on Nov 14, 2024. Keep track of upcoming events with our Earnings Calendar.
INO earnings for the last quarter are −1.19 USD per share, whereas the estimation was −1.10 USD resulting in a −8.02% surprise. The estimated earnings for the next quarter are −1.15 USD per share. See more details about Inovio Pharmaceuticals, Inc. earnings.
Inovio Pharmaceuticals, Inc. revenue for the last quarter amounts to 100.76 K USD, despite the estimated figure of 134.00 K USD. In the next quarter, revenue is expected to reach 112.83 K USD.
INO net income for the last quarter is −32.24 M USD, while the quarter before that showed −30.47 M USD of net income which accounts for −5.80% change. Track more Inovio Pharmaceuticals, Inc. financial stats to get the full picture.
No, INO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 9, 2024, the company has 122.00 employees. See our rating of the largest employees — is Inovio Pharmaceuticals, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Inovio Pharmaceuticals, Inc. EBITDA is −114.32 M USD, and current EBITDA margin is −15.83 K%. See more stats in Inovio Pharmaceuticals, Inc. financial statements.
Like other stocks, INO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Inovio Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Inovio Pharmaceuticals, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Inovio Pharmaceuticals, Inc. stock shows the sell signal. See more of Inovio Pharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.